Guido Cantisani

428 total citations
19 papers, 319 citations indexed

About

Guido Cantisani is a scholar working on Epidemiology, Surgery and Hepatology. According to data from OpenAlex, Guido Cantisani has authored 19 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 12 papers in Surgery and 12 papers in Hepatology. Recurrent topics in Guido Cantisani's work include Organ Transplantation Techniques and Outcomes (12 papers), Liver Disease and Transplantation (9 papers) and Liver Disease Diagnosis and Treatment (9 papers). Guido Cantisani is often cited by papers focused on Organ Transplantation Techniques and Outcomes (12 papers), Liver Disease and Transplantation (9 papers) and Liver Disease Diagnosis and Treatment (9 papers). Guido Cantisani collaborates with scholars based in Brazil, United States and France. Guido Cantisani's co-authors include Cláudio Augusto Marroni, Maria Lúcia Zanotelli, Ajácio Brandão, Ana Gleisner, Sandra Cristina Pereira Costa Fuchs, Ian Leipnitz, Styrbjörn Friman, Ferdinand Mühlbacher, Robert M. Jones and P. Aiden McCormick and has published in prestigious journals such as Journal of Hepatology, Liver Transplantation and Clinical Transplantation.

In The Last Decade

Guido Cantisani

18 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guido Cantisani Brazil 11 245 192 172 85 34 19 319
Christian Evangelista Garcia United Kingdom 7 250 1.0× 184 1.0× 146 0.8× 48 0.6× 18 0.5× 13 295
L Jennings United States 4 350 1.4× 313 1.6× 197 1.1× 111 1.3× 11 0.3× 6 380
Nikhil Kapila United States 7 148 0.6× 82 0.4× 81 0.5× 134 1.6× 16 0.5× 22 264
Jefree A. Shalev United States 8 148 0.6× 201 1.0× 140 0.8× 72 0.8× 21 0.6× 9 300
Jasper Bekker United Kingdom 5 343 1.4× 381 2.0× 76 0.4× 32 0.4× 64 1.9× 11 419
Mohammed Al‐Sebayel Saudi Arabia 8 112 0.5× 69 0.4× 90 0.5× 17 0.2× 34 1.0× 24 171
Pavani Reddy Taiwan 8 99 0.4× 233 1.2× 116 0.7× 224 2.6× 49 1.4× 8 364
Lawrence U. Liu United States 7 131 0.5× 125 0.7× 60 0.3× 39 0.5× 16 0.5× 12 317
Bruno Desschans Belgium 9 167 0.7× 218 1.1× 39 0.2× 68 0.8× 101 3.0× 16 258
Hisakazu Degawa Japan 11 117 0.5× 196 1.0× 37 0.2× 87 1.0× 135 4.0× 31 263

Countries citing papers authored by Guido Cantisani

Since Specialization
Citations

This map shows the geographic impact of Guido Cantisani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Cantisani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Cantisani more than expected).

Fields of papers citing papers by Guido Cantisani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Cantisani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Cantisani. The network helps show where Guido Cantisani may publish in the future.

Co-authorship network of co-authors of Guido Cantisani

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Cantisani. A scholar is included among the top collaborators of Guido Cantisani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Cantisani. Guido Cantisani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Leipnitz, Ian, Maria Lúcia Zanotelli, Judith Martini, et al.. (2015). Comparison Between IGL-1 and HTK Preservation Solutions in Deceased Donor Liver Transplantation. Transplantation Proceedings. 47(4). 888–893. 18 indexed citations
2.
Marroni, Cláudio Augusto, et al.. (2014). D-MELD does not predict post-liver transplantation survival: a single-center experience from Brazil. Annals of Hepatology. 13(6). 781–787. 4 indexed citations
3.
Perrillo, Robert, Marı́a Buti, François Durand, et al.. (2013). Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B. Liver Transplantation. 19(8). 887–895. 35 indexed citations
4.
Marroni, Cláudio Augusto, et al.. (2013). Liver retransplantation in adults: a 20–year experience of one center in southern Brazil. Annals of Hepatology. 12(6). 942–951. 6 indexed citations
5.
Marroni, Cláudio Augusto, et al.. (2013). Impact of creatinine values on MELD scores in male and female candidates for liver transplantation. Annals of Hepatology. 12(3). 434–439. 14 indexed citations
6.
Perrillo, Robert, François Durand, Michael Charlton, et al.. (2012). 535 SAFETY AND EFFICACY OF ENTECAVIR IN PATIENTS RECEIVING LIVER TRANSPLANT DUE TO CHRONIC HEPATITIS B. Journal of Hepatology. 56. S212–S212. 3 indexed citations
7.
8.
Brandão, Ajácio, Sandra Cristina Pereira Costa Fuchs, Ana Gleisner, et al.. (2009). MELD and other predictors of survival after liver transplantation. Clinical Transplantation. 23(2). 220–227. 38 indexed citations
9.
Brandão, Ajácio, Sandra Cristina Pereira Costa Fuchs, Ana Gleisner, et al.. (2008). Model for the end‐stage liver disease and death prediction in a cohort of Brazilian patients on the waiting list for liver transplantation. Clinical Transplantation. 22(5). 651–656. 14 indexed citations
10.
Marroni, Cláudio Augusto, et al.. (2006). Impact of Cytomegalovirus Infection on Long-Term Survival After Orthotopic Liver Transplantation. Transplantation Proceedings. 38(6). 1924–1925. 6 indexed citations
11.
Zanotelli, Maria Lúcia, J. Neumann, Ian Leipnitz, et al.. (2006). Randomized Clinical Assay for Hepatic Grafts Preservation With University of Wisconsin or Histidine-Tryptophan-Ketoglutarate Solutions in Liver Transplantion. Transplantation Proceedings. 38(6). 1872–1875. 35 indexed citations
12.
Levy, Gary, Gian Luca Grazi, Ferdinand Mühlbacher, et al.. (2006). 12-Month Follow-Up Analysis of A Multicenter, Randomized, Prospective Trial in De Novo Liver Transplant Recipients (Lis2t) Comparing Cyclosporine Microemulsion (C2 Monitoring) and Tacrolimus. Liver Transplantation. 12(10). 1464–1472. 73 indexed citations
13.
Cantisani, Guido, et al.. (2006). Enteric-Coated Mycophenolate Sodium Experience in Liver Transplant Patients. Transplantation Proceedings. 38(3). 932–933. 8 indexed citations
14.
Marroni, Cláudio Augusto, et al.. (2006). Risk Factors Associated With Cytomegalovirus Infection in Orthotopic Liver Transplant Patients. Transplantation Proceedings. 38(6). 1922–1923. 18 indexed citations
15.
Marroni, Cláudio Augusto, et al.. (2004). Risk factors associated with cytomegalovirus-positive antigenemia in orthotopic liver transplant patients. Transplantation Proceedings. 36(4). 961–963. 1 indexed citations
16.
Zanotelli, Maria Lúcia, Ajácio Brandão, Ian Leipnitz, et al.. (2002). Biliary tract complications after orthotopic liver transplantation in adult patients. Transplantation Proceedings. 34(2). 519–520. 15 indexed citations
17.
Brandão, Ajácio, et al.. (1999). Efficacy of a recombinant hepatitis B vaccine (Euvax-B) in adult patients awaiting liver transplantation: preliminary results. Transplantation Proceedings. 31(7). 3055–3056. 2 indexed citations
18.
Marroni, Cláudio Augusto, et al.. (1999). Diabetes mellitus and liver transplantation in adults. Transplantation Proceedings. 31(7). 3046–3046. 13 indexed citations
19.
Ferreira, Cristina Targa, Carlos Oscar Kieling, Sandra Maria Gonçalves Vieira, et al.. (1998). Transplante hepatico em criancas e adolescentes: relato dos primeiros 22 casos no Hospital de Clinicas de Porto Alegre. 42(3). 125–131.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian Evangelista Garcia Breakdown of academic impact, for papers by L Jennings Breakdown of academic impact, for papers by Nikhil Kapila Breakdown of academic impact, for papers by Jefree A. Shalev Breakdown of academic impact, for papers by Jasper Bekker Breakdown of academic impact, for papers by Mohammed Al‐Sebayel Breakdown of academic impact, for papers by Pavani Reddy Breakdown of academic impact, for papers by Lawrence U. Liu Breakdown of academic impact, for papers by Bruno Desschans Breakdown of academic impact, for papers by Hisakazu Degawa
Rankless by CCL
2026